Systematic Reviews
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jul 21, 2025; 31(27): 107740
Published online Jul 21, 2025. doi: 10.3748/wjg.v31.i27.107740
Figure 1
Figure 1 Hyperdynamic alterations in advanced chronic liver disease and post-transjugular intrahepatic portosystemic shunt[30]. Depicted: Hyperdynamic changes seen in advancing chronic liver disease (grey arrows), with transjugular intrahepatic portosystemic shunt changes (green) demonstrating haemodynamic changes with resultant effects. TIPS: Transjugular intrahepatic portosystemic shunt; RA: Right atrium; LV: Left ventricle; CO: Cardiac output.
Figure 2
Figure 2  Screening process: From identification to inclusion.
Figure 3
Figure 3  ROBINS-E, risk of bias tool on selected cohort studies[110].
Figure 4
Figure 4 Proposed algorithm for cardiovascular workup prior to transjugular intrahepatic portosystemic shunt procedure. TIPS: Transjugular intrahepatic portosystemic shunt; Cardiac history: History of peripheral oedema, congestive cardiac failure, pulmonary hypertension, valvular disease; ECG: Electrocardiogram; NT-proBNP: N-terminal pro-B-type natriuretic peptide; TTE: Transthoracic echocardiography; LV: Left ventricular; 2D-strain: Two-dimensional speckle-tracing echocardiography assessing for left atrial strain; RHC: Right heart catheterisation; MDT: Multi-disciplinary team gastroenterology, anaesthesiology, interventional radiology, cardiology inputs.